Metraipolis › archive › dc_bbdbd0f109b2

Prediction of tumor progression in intermediate and advanced hepatocellular carcinoma undergoing TACE combined with targeted immunotherapy — Europe PMC PMID:42109683

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42109683
DOI: 10.3389/fonc.2026.1678771
License (as archived): solo-consultazione
Archived: 2026-11-03T06:57:22.788Z
SHA-256 of the archived text: 25959ca75dd9d89194159a7ac21caf45ca4ba3ee7389512e6d4d1fba2e9b4a6e
Stable URL of this page: https://metraipolis.com/documento/dc_bbdbd0f109b2

How to cite

Prediction of tumor progression in intermediate and advanced hepatocellular carcinoma undergoing TACE combined with targeted immunotherapy — Europe PMC PMID:42109683 — Europe PMC (en), https://europepmc.org/article/MED/42109683 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bbdbd0f109b2 (Metraipolis archive dc_bbdbd0f109b2, sha256 25959ca75dd9d89194159a7ac21caf45ca4ba3ee7389512e6d4d1fba2e9b4a6e)

BibTeX

@misc{dcbbdbd0f109b2,
  title = {Prediction of tumor progression in intermediate and advanced hepatocellular carcinoma undergoing TACE combined with targeted immunotherapy — Europe PMC PMID:42109683},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42109683},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bbdbd0f109b2; sha256 25959ca75dd9d89194159a7ac21caf45ca4ba3ee7389512e6d4d1fba2e9b4a6e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42109683. Agents can read the archived copy with the MCP tool read_document.